Roughly one billion people worldwide are estimated to live with obstructive sleep apnea, and a large share of them don't know it. For the ones who do get diagno ...
Morning Overview on MSN
A VA study of 588,000 patients ties GLP-1 drugs to a 35% higher risk of vision loss
Millions of Americans taking GLP-1 receptor agonists for type 2 diabetes or weight loss now face a new safety question. A ...
Morning Overview on MSN
Ozempic helped adults over 65 shed more than 15% of their body weight in a new study
Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...
A single night of sleep testing may not be enough to diagnose sleep apnea, with new Flinders University research revealing ...
The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.
Becoming a new mother brings more than just joyful chaos it delivers a profound and persistent sleep shock. A new study reveals that first-time moms lose not just total sleep, but crucial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results